Concepedia
Statistics
Publications
22
Citations
983
H-Index
16
Active since
1976
Affiliations
AstraZeneca (Sweden)(Current)
Umeå University
Active Biotech (Sweden)
Lund University
Linnaeus University
Tomas Fex is an author at AstraZeneca (Sweden) specializing in medicine, natural sciences, and biochemistry.
Top concepts
MedicineNatural SciencesBiochemistryDrug DiscoveryPharmacologyChemistryMedicinal ChemistryEngineeringBioanalysisOrganic Chemistry
Publications per year
1976–2020
Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders: Structure−Activity Relationship
Stig Jönsson, Gunnar Andersson, Tomas Fex et al. · Journal of Medicinal Chemistry · 2004 · 156 citations
Design and Evaluation of Pilicides: Potential Novel Antibacterial Agents Directed Against UropathogenicEscherichia coli
Anette Svensson, Andréas Larsson, Hans Emtenäs et al. · ChemBioChem · 2001 · 135 citations
Engineering, Infectious Disease, Antimicrobial Chemotherapy +17
Clavatadine A, A Natural Product with Selective Recognition and Irreversible Inhibition of Factor XIa
Malcolm S. Buchanan, Anthony R. Carroll, Deborah Wessling et al. · Journal of Medicinal Chemistry · 2008 · 79 citations · Full text
Crystal Structure, Medicinal Chemistry, Inhibitory Activity +14
Weak affinity chromatography as a new approach for fragment screening in drug discovery
Minh‐Dao Duong‐Thi, Elinor Meiby, Maria Bergström et al. · Analytical Biochemistry · 2011 · 74 citations
Fragment Screening, Medicinal Chemistry, Hit Identification +14
Use of 19F NMR spectroscopy to evaluate reactions in solid phase organic synthesis
Anette Svensson, Tomas Fex, Jan Kihlberg · Tetrahedron Letters · 1996 · 61 citations
Chemical Engineering, Engineering, Nmr Spectroscopy +6
1–5 of 22